Busulphan and leukaemia recurrent Patient Reports February 13, 2012

Busulphan Side Effects Report #5244207-2
Busulphan side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 14, 2007. Male patient, 63 years of age, was diagnosed with graft versus host disease and was treated with Busulphan. After drug was administered, patient experienced the following side effects: acute graft versus host disease in skin, cerebral toxoplasmosis, leukaemia recurrent. Busulphan dosage: unknown. During the same period patient was treated with CAMPATH, CYCLOSPORINE, FLUDARABINE, CYTARABINE, NEUPOGEN, IDARUBICIN, SULFAMETHOXAZOLE, TRIMETOPRIM. Patient died.